SCHEMBL4464897

SCHEMBL4464897

N#Cc1cccc(-c2cnc(N)c3c(-c4ccc(F)c(Cl)c4)csc23)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHB4 P54760 10/20 0.70
KDR P35968 3/20 0.68
BRAF P15056 5/20 0.45
BTK Q06187 1/20 0.42
AURKA O14965 2/20 0.42
ROCK2 O75116 2/20 0.42
MAP4K4 O95819 2/20 0.42
ABL1 P00519 2/20 0.42
FYN P06241 2/20 0.42
CSF1R P07333 2/20 0.42
LYN P07948 2/20 0.42
KIT P10721 2/20 0.42
FGFR1 P11362 2/20 0.42
FLT1 P17948 2/20 0.42
AXL P30530 2/20 0.42
FLT4 P35916 2/20 0.42
FLT3 P36888 2/20 0.42
CLK2 P49760 2/20 0.42
BLK P51451 2/20 0.42
NEK2 P51955 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4474048 0.82 EPHB4 (1.00) EPHB4KDRBRAF
Gw856804X SCHEMBL4471490 0.81 EPHB4 (1.00) EPHB4KDRBRAFAURKAROCK2
Gw856804X SCHEMBL32678604 0.81 EPHB4 (1.00) EPHB4KDRBRAFAURKAROCK2
Gw856804X SCHEMBL32678600 0.81 EPHB4 (1.00) EPHB4KDRBRAFAURKAROCK2
Gw856804X SCHEMBL32678602 0.81 EPHB4 (1.00) EPHB4KDRBRAFAURKAROCK2
SCHEMBL4461110 0.80 EPHB4 (0.71) EPHB4KDRBRAFBTKAURKA
SCHEMBL4473188 0.80 EPHB4 (1.00) EPHB4KDRBRAFAURKAROCK2
SCHEMBL4467257 0.79 EPHB4 (1.00) EPHB4KDRBRAFAURKAROCK2
SCHEMBL13708295 0.78 EPHB4 (0.68) EPHB4KDRBRAFAURKAROCK2
SCHEMBL4472583 0.77 EPHB4 (1.00) EPHB4KDRBRAFBTKAURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7592352-B2 Substituted thieno and furo-pyridines SMITHKLINE BEECHAM CORPORATION (US) 2009-09-22 US claimed
US-20080182868-A1 Novel chemical compounds SMITHKLINE BEECHAM CORPORATION 2008-07-31 US claimed
JP-2006528685-A 2006-12-21 JP claimed
EP-1620094-A2 NOVEL CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2006-02-01 EP claimed
WO-2004100947-A2 NOVEL CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2004-11-25 WO claimed
US-7592352-B2 Substituted thieno and furo-pyridines SMITHKLINE BEECHAM CORPORATION (US) 2009-09-22 US disclosed
US-7592352-B2 Substituted thieno and furo-pyridines SMITHKLINE BEECHAM CORPORATION (US) 2009-09-22 US disclosed
US-7592352-B2 Substituted thieno and furo-pyridines SMITHKLINE BEECHAM CORPORATION (US) 2009-09-22 US disclosed
US-20080182868-A1 Novel chemical compounds SMITHKLINE BEECHAM CORPORATION 2008-07-31 US disclosed
US-20080182868-A1 Novel chemical compounds SMITHKLINE BEECHAM CORPORATION 2008-07-31 US disclosed
US-20080182868-A1 Novel chemical compounds SMITHKLINE BEECHAM CORPORATION 2008-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080182868-A1 Novel chemical compounds HRAS, VHL, TP53 EPHB4 2484/4885KDR 983/4885BRAF 23/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.